The responsibility of the infectious disease community for the optimal use of antimicrobial agents - PubMed (original) (raw)

Clinical Trial

The responsibility of the infectious disease community for the optimal use of antimicrobial agents

C M Kunin. J Infect Dis. 1985 Mar.

Abstract

Antimicrobial agents are a critical element of the therapeutic armamentarium of modern medicine. How well they are used reflects our ability to treat and prevent infectious diseases. The major consideration for proper usage is to select the optimal agent at the proper dosage. Secondary, but important concerns are to minimize the emergence of resistance and to provide health services at a reasonable cost. The infectious disease community must work in concert with the pharmaceutical industry to achieve these goals. The relations of infectious disease physicians with the industry have been remarkably effective in evaluating and introducing new drugs, however, it is natural that conflicts should arise. Although the overall accomplishments have been outstanding, there is considerable evidence that antimicrobial agents are often abused and used excessively. This paper outlines some of the issues of marketing and the problems inherent in industry-sponsored trials. As specialties other than infectious diseases have encountered major difficulties, it is timely that this society adopts a code of ethical conduct for its work with industrial sponsors and takes the initiative in developing programs for education of other physicians in the field of infectious diseases and antimicrobial therapy both in this country and in developing nations.

PubMed Disclaimer

Cited by

Prescribing practice and cost of antibacterial prophylaxis for surgery at a US Veteran Affairs hospital.
Ryono RA, Jones KS, Coleman RW, Holodniy M. Ryono RA, et al. Pharmacoeconomics. 1996 Dec;10(6):630-43. doi: 10.2165/00019053-199610060-00009. Pharmacoeconomics. 1996. PMID: 10164063 Clinical Trial.
Intravenous-to-oral conversion therapy for antimicrobials.
Conly JM, Shafran SD. Conly JM, et al. Can J Infect Dis. 1994 Jan;5(1):15-6. doi: 10.1155/1994/428375. Can J Infect Dis. 1994. PMID: 22346475 Free PMC article. No abstract available.
Practical considerations when treating children with antimicrobials in the outpatient setting.
Werk LN, Bauchner H. Werk LN, et al. Drugs. 1998 Jun;55(6):779-90. doi: 10.2165/00003495-199855060-00005. Drugs. 1998. PMID: 9617593 Review.
Evolving approaches to management of quality in clinical microbiology.
Bartlett RC, Mazens-Sullivan M, Tetreault JZ, Lobel S, Nivard J. Bartlett RC, et al. Clin Microbiol Rev. 1994 Jan;7(1):55-88. doi: 10.1128/CMR.7.1.55. Clin Microbiol Rev. 1994. PMID: 8118791 Free PMC article. Review.
The role of the infectious diseases physician in setting guidelines for antimicrobial use.
Bryan CS. Bryan CS. Bull N Y Acad Med. 1987 Jul-Aug;63(6):627-37. Bull N Y Acad Med. 1987. PMID: 3479215 Free PMC article. No abstract available.

The responsibility of the infectious disease community for the optimal use of antimicrobial agents - PubMed (original) (raw)